Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$192K Sell
20,000
-155,405
-89% -$1.88M ﹤0.01% 1047
2025
Q4
$2.15M Buy
175,405
+23,163
+15% +$308K 0.01% 439
2025
Q3
$2.03M Buy
+152,242
New +$2.08M 0.01% 446

Other funds holding CARL

TD Waterhouse Canada's CARL Position: Q1 2026 in Review

TD Waterhouse Canada reduced its Carlsmed (CARL) stake by 89% in Q1 2026, selling an estimated $1.88M and leaving 20,000 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #1047.

TD Waterhouse Canada first reported a position in CARL in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.15M in Q4 2025. 66 funds tracked by Wall St. Rank hold CARL as of Q1 2026.

  • TD Waterhouse Canada held 20,000 shares of Carlsmed worth $192K as of Q1 2026.
  • TD Waterhouse Canada sold 155,405 Carlsmed shares in Q1 2026, an estimated $1.88M.
  • Carlsmed made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #1047 holding.
  • TD Waterhouse Canada first reported a position in Carlsmed in Q3 2025 and has held it in 3 quarters since.
  • TD Waterhouse Canada's Carlsmed position peaked at $2.15M in Q4 2025.
  • 66 funds tracked by Wall St. Rank held Carlsmed as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.